JPS63133990A - Production of pyruvic acid - Google Patents
Production of pyruvic acidInfo
- Publication number
- JPS63133990A JPS63133990A JP27942686A JP27942686A JPS63133990A JP S63133990 A JPS63133990 A JP S63133990A JP 27942686 A JP27942686 A JP 27942686A JP 27942686 A JP27942686 A JP 27942686A JP S63133990 A JPS63133990 A JP S63133990A
- Authority
- JP
- Japan
- Prior art keywords
- pyruvic acid
- enzyme
- extract
- microorganism
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 229940107700 pyruvic acid Drugs 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 244000005700 microbiome Species 0.000 claims abstract description 20
- 102000004190 Enzymes Human genes 0.000 claims abstract description 19
- 108090000790 Enzymes Proteins 0.000 claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 18
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 abstract description 20
- 239000000243 solution Substances 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 9
- 102000007698 Alcohol dehydrogenase Human genes 0.000 abstract description 5
- 108010021809 Alcohol dehydrogenase Proteins 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 abstract description 4
- 108010025188 Alcohol oxidase Proteins 0.000 abstract description 4
- 108091023020 Aldehyde Oxidase Proteins 0.000 abstract description 4
- 102000048262 Aldehyde oxidases Human genes 0.000 abstract description 4
- 108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract 2
- LJCNDNBULVLKSG-UHFFFAOYSA-N 2-aminoacetic acid;butane Chemical compound CCCC.CCCC.NCC(O)=O LJCNDNBULVLKSG-UHFFFAOYSA-N 0.000 abstract 1
- 108010020056 Hydrogenase Proteins 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 238000000638 solvent extraction Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 229940088598 enzyme Drugs 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 5
- 229940076788 pyruvate Drugs 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 229940054269 sodium pyruvate Drugs 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 3
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- QLDHWVVRQCGZLE-UHFFFAOYSA-N acetyl cyanide Chemical compound CC(=O)C#N QLDHWVVRQCGZLE-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- DAQHMCWYXJEOCG-UHFFFAOYSA-N 2-oxopropanoic acid;sodium Chemical compound [Na].CC(=O)C(O)=O DAQHMCWYXJEOCG-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 101100071346 Caenorhabditis elegans hpo-40 gene Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000589344 Methylomonas Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000320412 Ogataea angusta Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明はヒドロキシアセトン(CH,C0CH,OH)
またはメチルグリオキサール(CH,C0CHO)より
ピルビン酸(CH,C0C00H)を製造法する方法に
関する。Detailed Description of the Invention (Industrial Field of Application) The present invention provides hydroxyacetone (CH, COCH, OH)
Alternatively, the present invention relates to a method for producing pyruvic acid (CH, C0C00H) from methylglyoxal (CH, C0CHO).
ピルビン酸は解糖系で生じる中間代謝産物であり、生体
細胞の中では糖代謝・アミノ酸代謝において重要な役割
を果しており、細胞に対して代謝促進物質として作用す
ることが知られている。Pyruvate is an intermediate metabolite produced in the glycolytic system, and plays an important role in sugar metabolism and amino acid metabolism in living cells, and is known to act as a metabolic promoter on cells.
また工業的にはアラニン、チロシン、トリプトファン等
の各種アミノ酸の製造原料として、更に種々の医薬製造
の中間原料として広い用途を有している。従って安価に
製造し得れば柱々の合成原料として、また代謝促進物質
として極めて有用である。Industrially, it has a wide range of uses as a raw material for the production of various amino acids such as alanine, tyrosine, and tryptophan, and as an intermediate raw material for the production of various pharmaceuticals. Therefore, if it can be produced at low cost, it will be extremely useful as a raw material for the synthesis of pillars and as a metabolic promoter.
(従来の技術)
従来、ピルビン酸の製造法としては種々の微生物による
発酵法、シアン化ナトリウムと塩化アセチルを反応させ
てシアン化アセチルを合成し、これを加水分解する方法
、または乳酸またはヒドロキシアセトンを金属触媒を用
いて乳化する方法等が知られている。(Prior art) Conventionally, methods for producing pyruvic acid include fermentation using various microorganisms, reacting sodium cyanide with acetyl chloride to synthesize acetyl cyanide, and hydrolyzing this, or using lactic acid or hydroxyacetone. A method of emulsifying the compound using a metal catalyst is known.
(発明が解決しようとする問題点)
しかしながら、発酵法およびシアン化アセチルを経由す
る方法は収率が低く副生成物を多量に生成し、金属触媒
を用いる方法は触媒が高価であり、触媒の再生も繁雑で
あることから、工業的に効果的にピルビン酸を製造する
には必ずしも有利な方法とはなっていない。そこで木発
明者等は工業的にを利にピルビン酸を製造する目的で、
鋭意研究を行なった結果、安価なヒドロキンアセトンま
たはその酸化物であるメチルグリオキサールを酵素、微
生物または該抽出物により酸化することでピルビン酸が
効率良く生成されることを見出し本発明を完成するに至
った。(Problems to be solved by the invention) However, the fermentation method and the method via acetyl cyanide have low yields and produce large amounts of by-products, and the method using a metal catalyst requires an expensive catalyst. Since regeneration is also complicated, it is not necessarily an advantageous method for producing pyruvic acid industrially and effectively. Therefore, wood inventors and others aimed to produce pyruvic acid for industrial purposes.
As a result of intensive research, we discovered that pyruvic acid can be efficiently produced by oxidizing inexpensive hydroquinacetone or its oxide, methylglyoxal, with enzymes, microorganisms, or its extracts.To complete the present invention. It's arrived.
(問題点を解決するための手段)
本発明は、ヒドロキンアセトンまたはメチルグリオキサ
ールに酵素または微生物または該抽出物を作用させてピ
ルビン酸を生成することを特徴とするピルビン酸の製造
法である。(Means for Solving the Problems) The present invention is a method for producing pyruvic acid, which is characterized in that pyruvic acid is produced by reacting hydroquine acetone or methylglyoxal with an enzyme, a microorganism, or an extract thereof.
本発明において用いられる酵素としては、ヒドロキンア
セトンまたはメチルグリオキサールルビン酸に変換する
酵素であり、たとえばアルコールオキンダーゼ,アルコ
ールデヒドロゲナーゼ、アルデヒドオキシダーゼ、アル
デヒドデヒドロゲナーゼ、ホルムアルデヒドデヒドロゲ
ナーゼなどが挙げられる。また微生物としては、メタ/
−ル資化能を有する細菌、酵母、放線菌およびカビなど
が挙げられる。The enzyme used in the present invention is an enzyme that converts hydroquine acetone or methylglyoxal rubic acid, and examples thereof include alcohol okindase, alcohol dehydrogenase, aldehyde oxidase, aldehyde dehydrogenase, and formaldehyde dehydrogenase. Also, as a microorganism, meta/
Examples include bacteria, yeast, actinomycetes, and molds that have the ability to assimilate bacteria.
ヒドロキンアセトンに作用してピルビン酸を生成する酵
素としては、(1)アルコールオキシダーゼ又はθ0
アルコールデヒドロゲナーゼ、IiiD(i)アルコー
ルオキシダーゼGOアルコールデヒドロゲーゼとアルデ
ヒドオキシダーゼ、アルデヒドデヒドロゲナーゼ又はホ
ルムアルデヒドロゲーナーゼの組合せを使用する。Enzymes that act on hydroquine acetone to produce pyruvate include (1) alcohol oxidase or θ0
Alcohol dehydrogenase, IIID(i) Alcohol oxidase GO A combination of alcohol dehydrogenase and aldehyde oxidase, aldehyde dehydrogenase or formal dehydrogenase is used.
ヒドロキシアセトン列用してピルビン酸を生成する微生
物又は該抽出物としては上記酵素を生産する微生物又は
該抽出物であればよい。微生物としては例えばシュード
モナス、メチロモナスなどの細菌、サツカロミセス、ピ
キア、ハンヌセラ、トルロプシス、キャンディダ、クロ
エケラ、ロドトルラなどの酵母、ストレプトミセスなど
の放線菌、ブリオフラジウム、パエンロミセスナトのカ
ビが挙げられる。The microorganism or extract thereof that produces pyruvate using the hydroxyacetone series may be any microorganism or extract thereof that produces the above-mentioned enzyme. Examples of microorganisms include bacteria such as Pseudomonas and Methylomonas, yeasts such as Satucharomyces, Pichia, Hannusella, Torulopsis, Candida, Chloechera, and Rhodotorula, actinomycetes such as Streptomyces, and molds such as Bryophragium and Paenromyces nato. .
微生物からの抽出物としては、−上記微生物の培養菌体
又は培養液に種々の抽出法を適用して得られたものを使
用する。抽出方法としては、リゾチーム、ザイモリエー
ル等の溶菌酵素、ダイノミール、界面活性剤、EDTA
,塩類、酸処理、アルカリ処理、を機溶剤、カオトロピ
ックイオン、超音波、フレンチプレス、その他の物理的
な破砕などを用いる。As extracts from microorganisms, those obtained by applying various extraction methods to cultured cells or culture fluids of the above-mentioned microorganisms are used. Extraction methods include lysozyme, lytic enzymes such as Zymoliel, Dynomir, surfactants, and EDTA.
, using salts, acid treatment, alkali treatment, organic solvents, chaotropic ions, ultrasound, French press, and other physical crushing methods.
メチルグリオキサールに作用してピルビン酸を生成する
酵素としては、(i)アルコールオキシダーゼ、(IO
アルコールデヒドロゲナーゼ, Gii)アルデヒ
ドオキシダーゼ、Oo アルデヒドデヒドロゲナーゼ又
は(v)ホルムアルデヒドデヒドロゲナーゼを使用する
。Enzymes that act on methylglyoxal to produce pyruvate include (i) alcohol oxidase, (IO
Using alcohol dehydrogenase, Gii) aldehyde oxidase, Oo aldehyde dehydrogenase or (v) formaldehyde dehydrogenase.
メチルグリオキサールに作用してピルビン酸を生成する
微生物又は該抽出物としては、上記酵素を生産する微生
物又は該抽出物であればよい。微生物としては前述のも
のが挙げられる。抽出方法も前述のものが挙げられる。The microorganism or extract thereof that acts on methylglyoxal to produce pyruvate may be any microorganism or extract thereof that produces the above-mentioned enzyme. Examples of microorganisms include those mentioned above. Examples of the extraction method include those mentioned above.
本発明方法は前記酵素または微生物または該抽出物を適
当な無機塩類を含むヒドロキシアセトンまたはメチルグ
リオキサールの水溶液に作用させ、ピルビン酸を生成せ
しめるものであり、本発明において使用され得る無機塩
類としては、カリウム、ナトリウム、マンガン、マグネ
シウム、亜鉛、鉄、銅、チタンなどの金属塩類や、硫酸
、リン酸、塩酸、硝酸、酢酸などの塩類が使用できる。In the method of the present invention, pyruvic acid is produced by causing the enzyme, microorganism, or extract thereof to act on an aqueous solution of hydroxyacetone or methylglyoxal containing appropriate inorganic salts, and the inorganic salts that can be used in the present invention include: Metal salts such as potassium, sodium, manganese, magnesium, zinc, iron, copper, and titanium, and salts such as sulfuric acid, phosphoric acid, hydrochloric acid, nitric acid, and acetic acid can be used.
反応液のpHは4〜9とし、反応温度は4〜40°Cで
反応を行う。反応は酵素または微生物または該抽出物を
反応に直接溶解または懸回させても良いし、酵素または
微生物または該抽出物を固定化し、該固定化物に反応液
を接触させても良い。The pH of the reaction solution is 4 to 9, and the reaction temperature is 4 to 40°C. The reaction may be carried out by directly dissolving or suspending the enzyme, the microorganism, or the extract thereof, or by immobilizing the enzyme, the microorganism, or the extract, and bringing the reaction solution into contact with the immobilized product.
反応終了後は反応液を濾過または遠心分離を行ない、菌
体及びその他の不純物を除去し、得られたin液または
遠心分離上清液に例えば塩酸を添加してpH2以下の塩
酸酸性液とした後、疎水性の有機溶媒で抽出する。ここ
で用いられる疎水性有機溶媒としてはエチルエーテル、
メチルエチルケトン、クロロホルム、石油エーテル等が
有効である。After the reaction is completed, the reaction solution is filtered or centrifuged to remove bacterial cells and other impurities, and the resulting in solution or centrifugation supernatant is added with, for example, hydrochloric acid to make a hydrochloric acid acidic solution with a pH of 2 or less. Afterwards, it is extracted with a hydrophobic organic solvent. The hydrophobic organic solvent used here is ethyl ether,
Methyl ethyl ketone, chloroform, petroleum ether, etc. are effective.
前記の有機溶媒抽出液を50℃以下で減圧濃縮し、該濃
縮物を冷水に溶解した後、苛性ソーダ水溶液を添加して
pH8前後に調整した後、エタノールを添加する。前記
エタノール添加によりピルビン酸はピルビン酸ナトリウ
ムとして結晶化し沈殿を形成するので、該エタノール沈
殿物を濾過または遠心分離によって集め、減圧乾爆して
ピルビン酸ナトリウムの粉末として採取する。The organic solvent extract is concentrated under reduced pressure at 50° C. or lower, the concentrate is dissolved in cold water, and aqueous caustic soda solution is added to adjust the pH to around 8, followed by the addition of ethanol. By adding ethanol, pyruvic acid crystallizes as sodium pyruvate to form a precipitate, so the ethanol precipitate is collected by filtration or centrifugation, and dried under reduced pressure to be collected as a powder of sodium pyruvate.
本発明では医薬品、工業化学品の製造中間原料として、
または代謝促進物質として工業的に極めて仔用なピルビ
ン酸を安価に効率よく製造することができる。In the present invention, as an intermediate raw material for manufacturing pharmaceuticals and industrial chemicals,
Alternatively, pyruvic acid, which is industrially very useful as a metabolic promoter, can be produced efficiently and at low cost.
(実施例) 次に本発明を実施例により更に詳しく説明する。(Example) Next, the present invention will be explained in more detail with reference to Examples.
実施例1
ヒF Oキノ7 セ) ン0.5 %、Kt HP O
40,8%、FeCQ、 −68,OO,14%を蒸留
水に溶解し、pH7,0に調整した。該溶液10mff
を100m!!容三角フラスコに分注し、これにアルコ
ールオキンダーゼ(東洋紡製)を100U添加し、30
°C13o時間振盪反応した。反応終了後、該反応液の
ピルビン酸量を定量したところ0.047%のピルビン
酸が生成された。Example 1 0.5%, Kt HP O
40.8%, FeCQ, -68,OO, 14% was dissolved in distilled water and adjusted to pH 7.0. The solution 10mff
100m! ! Dispense into a volume Erlenmeyer flask, add 100 U of alcohol okindase (manufactured by Toyobo), and add 30
The reaction was carried out by shaking at 13°C for an hour. After the reaction was completed, the amount of pyruvic acid in the reaction solution was determined and 0.047% of pyruvic acid was produced.
実施例2
メチルグリオキサール0.5%、K、 HPO40,8
%、F e CQ s ・6 H−00,14%、NA
D5%を蒸留水に溶解しpH7,0に調整した。該溶液
10m[をLoomg容三角フラスコに分注し、ホルム
アルデヒドデヒドロゲナーゼ(東洋紡製)を50U添加
し、30’C110時間振盪反応した。反応終了後、該
反応液のピルビン酸■を定量したところ0.36%のピ
ルビン酸が生成された。Example 2 Methylglyoxal 0.5%, K, HPO40.8
%, Fe CQ s ・6 H-00, 14%, NA
D5% was dissolved in distilled water and adjusted to pH 7.0. 10 m of the solution was dispensed into a Loomg Erlenmeyer flask, 50 U of formaldehyde dehydrogenase (manufactured by Toyobo) was added, and a shaking reaction was performed at 30'C for 110 hours. After the reaction was completed, the amount of pyruvic acid in the reaction solution was determined, and 0.36% of pyruvic acid was produced.
実施例3
メタノール2.0%、ポリペプトン0.05%、酵母エ
キス0.05%、コーンスチープリッ力−0,5%、K
I HPO40,4%、ZnSO4*7Ht O0,0
02%、Mg5CL ”7H,OO,075%、FeC
25”6Ht OO,002%を水道水に溶解し、pH
5,0に調整し、120°Cで20分間オートクレーブ
滅菌した培地を、得た。この培地50mffを500m
g容坂ロフラスコに分注し、同じ組成の培地で予め30
℃、10時間振Ω培養したハンセヌラ・ポリモルファI
FO1476菌株の培養菌体液を1.5mff1(対
培地当り3%相当)接種し、30℃で50時間振盪培養
した。培養後、冷却下に遠心分離し、1.1gの生菌体
を得た。Example 3 Methanol 2.0%, polypeptone 0.05%, yeast extract 0.05%, corn steep force -0.5%, K
I HPO40.4%, ZnSO4*7Ht O0.0
02%, Mg5CL”7H,OO,075%, FeC
Dissolve 25”6Ht OO, 002% in tap water and adjust the pH
A culture medium adjusted to 5.0 and sterilized by autoclaving at 120°C for 20 minutes was obtained. 50 mff of this medium
Dispense g into Yosaka Lough flasks and pre-incubate 30 g with medium of the same composition.
Hansenula polymorpha I incubated at ℃ for 10 hours with shaking
A cultured cell fluid of the FO1476 strain was inoculated at 1.5 mff1 (equivalent to 3% per medium) and cultured with shaking at 30°C for 50 hours. After culturing, the mixture was centrifuged under cooling to obtain 1.1 g of viable bacterial cells.
ヒドロキシアセトン5Va、KI HPO40,35%
、K、 HPo。Hydroxyacetone 5Va, KI HPO40, 35%
, K., HPo.
0.55%を蒸留水に溶解し、pH6,0に調整した。0.55% was dissolved in distilled water and adjusted to pH 6.0.
該溶液10mgを100mQ容三角フラスコに分注し、
これに得られた生菌体0.5gを添加し、10°C14
o時間振W反応した。反応終了後、遠心分離し、菌体を
除去し、上li!f液を得、該上清液のピルビン酸量を
定量したところ、0.079%のピルビン酸が生成され
た。Dispense 10 mg of the solution into a 100 mQ Erlenmeyer flask,
Add 0.5 g of the obtained viable bacterial cells to this and hold at 10°C14
o Time tremor W reacted. After the reaction is completed, centrifuge to remove the bacterial cells, and remove the li! When liquid f was obtained and the amount of pyruvic acid in the supernatant liquid was determined, 0.079% pyruvic acid was produced.
実施例4
アルギン酸ナトリウム2gを蒸留水100mfに溶解し
、pH7,0に調整した後、アルコールオキンダーゼ2
000Uを添加し、撹拌した。これを5%塩化力ルンウ
ム溶液中に滴下し、直径0.5〜1、 O、、のビーズ
状にゲル化させた。Example 4 After dissolving 2 g of sodium alginate in 100 mf of distilled water and adjusting the pH to 7.0, alcohol okindase 2
000U was added and stirred. This was dropped into a 5% chloride solution and gelled into beads with a diameter of 0.5 to 1.0 mm.
該ゲルを直径’l Oc箇、長さ1mのガラス製カラム
に充填し、20 m Mのリン酸緩衝液、pH7,0を
300mQ通液する。ヒドロキシアセトン5%、K、H
PO40,8%、FeCQs a6Hx OO,14
%を蒸留水に溶解し、I) H7,Oに調整し、該溶液
300mQを2.5 m91分の流速でカラムに循環さ
せた。The gel was packed into a glass column with a diameter of 'lOc and a length of 1 m, and 300 mQ of 20 mM phosphate buffer, pH 7.0, was passed through the column. Hydroxyacetone 5%, K, H
PO40,8%, FeCQs a6Hx OO,14
% was dissolved in distilled water and adjusted to I) H7,O, and 300 mQ of the solution was circulated through the column at a flow rate of 2.5 m91 min.
30°Cにて循環反応させた後、ピルビン酸量を定量し
たところ、0.063%のピルビン酸が生成された。After the cyclic reaction at 30°C, the amount of pyruvic acid was determined, and 0.063% of pyruvic acid was produced.
実施例5
アクリルアミドモノマー1.5g1N、N’−メチレン
ビスアクリルアミドsomg、実施例3と同様にして得
られた酵母生菌体0.2gを20mMのリン酸緩衝液1
) H7,0,8mgに溶解または!i!!澗し、該混
合液に重合液に重合促進剤として5%のβ−ツメチルア
ミノプロピオニトリル1− Om Q 、および重合開
始剤として1%のベルオクソ2硫酸カリウム1.0m+
!を添加し、23℃で10分間重合反応を行ない、直径
2〜51■のビーズ状のポリアクリルアミドゲルを得た
。メチルグリオキール2.0%、K、HPO40,8%
、FeCts ”68m OO,14%を蒸留水に溶
解し、1)H6,Oに調整した。該溶液100mtをビ
ーカーに分注し、調整したポリアクリルアミドゲル10
gを添加し、スターラーで撹拌しながら10℃、30時
間反応させた。反応終了後、反応液のピルビン酸量を足
口したところ、0.014%のピルビン酸が生成された
。Example 5 1.5 g of acrylamide monomer 1N, N'-methylenebisacrylamide somg, and 0.2 g of live yeast cells obtained in the same manner as in Example 3 were added to 20 mM phosphate buffer 1
) Dissolved in H7,0,8mg or! i! ! 5% of β-tumethylaminopropionitrile 1- Om Q as a polymerization accelerator and 1.0 m+ of potassium beroxo-2-sulfate as a polymerization initiator were added to the polymerization solution.
! was added and a polymerization reaction was carried out at 23°C for 10 minutes to obtain bead-shaped polyacrylamide gels having a diameter of 2 to 51 cm. Methylglyokyl 2.0%, K, HPO40.8%
, FeCts "68m OO, 14% was dissolved in distilled water and adjusted to 1) H6,O. 100mt of the solution was dispensed into a beaker and the prepared polyacrylamide gel 10
g was added thereto, and the mixture was reacted at 10° C. for 30 hours while stirring with a stirrer. After the reaction was completed, the amount of pyruvic acid in the reaction solution was measured, and 0.014% pyruvic acid was produced.
実施例6
実施例1と同様にして100mQ容三角フラスコに10
meづつ、実施例1と同様のヒドロキンアセトン溶液を
作成し、分注、同じ(実施例1と同様の方法でアルコー
ルオキンダーゼを添加し、30″0130時間振1反応
した。反応終了後、該反応液100mQをとり、塩酸を
加えてpH2以下とじ100mQのエチルエーテルで3
回抽出し、抽出液(エーテル届)を合わせて50°C以
下で減圧濃縮した。析出したピルビン酸を10mQの冷
水に溶解後苛性ソーダ液を少しづつ加えてpH6,0と
した後、エタノール滴下したところ、ピルビン酸ソーダ
のの結晶を析出した。続いてピルビン酸ソーダをグラス
フィルター上に集め、エタノールで洗浄後、減圧下に乾
爆して粉末0.14gを得た。この粉末0.1gを正確
に秤取し、冷水に溶解後、乳酸脱水素酵素を用いて常法
に従ってピルビン酸量を測定した結果、96.1%がピ
ルビン酸ソーダであった。Example 6 In the same manner as in Example 1, 10
Prepare the same hydroquine acetone solution as in Example 1, dispense it, add alcohol okindase in the same manner as in Example 1, and shake it for 30 mm for 130 hours. After the reaction is completed. Take 100 mQ of the reaction solution, add hydrochloric acid to adjust the pH to below 2, and dilute with 100 mQ of ethyl ether.
The extracts were extracted twice and the extracts (notified with ether) were combined and concentrated under reduced pressure at below 50°C. After dissolving the precipitated pyruvic acid in 10 mQ of cold water, a caustic soda solution was added little by little to adjust the pH to 6.0, and ethanol was added dropwise to precipitate crystals of sodium pyruvic acid. Subsequently, sodium pyruvate was collected on a glass filter, washed with ethanol, and then dry-exploded under reduced pressure to obtain 0.14 g of powder. After accurately weighing 0.1 g of this powder and dissolving it in cold water, the amount of pyruvic acid was measured according to a conventional method using lactate dehydrogenase. As a result, 96.1% was sodium pyruvate.
(発明の効果)
本発明はヒドロキノアセトンまたはメチルグリオキサー
ルに酵素または微生物または該抽出物を作用させること
によりピルビン酸を得ることができる。本発明では実施
例1〜6に示される如く、短時間でのンしいピルピノ酸
の生成が可能であり、効率的なピルビン酸の製造法とな
ることが明らかとなった。(Effects of the Invention) According to the present invention, pyruvic acid can be obtained by reacting hydroquinoacetone or methylglyoxal with an enzyme, a microorganism, or an extract thereof. As shown in Examples 1 to 6, it has been revealed that the present invention enables the production of pyrupinic acid in a short time and is an efficient method for producing pyruvic acid.
Claims (1)
素または微生物または該抽出物を作用させてピルビン酸
を生成させることを特徴とするピルビン酸の製造法。1. A method for producing pyruvic acid, which comprises reacting hydroxyacetone or methylglyoxal with an enzyme, a microorganism, or an extract thereof to produce pyruvic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27942686A JPS63133990A (en) | 1986-11-21 | 1986-11-21 | Production of pyruvic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27942686A JPS63133990A (en) | 1986-11-21 | 1986-11-21 | Production of pyruvic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63133990A true JPS63133990A (en) | 1988-06-06 |
Family
ID=17610911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27942686A Pending JPS63133990A (en) | 1986-11-21 | 1986-11-21 | Production of pyruvic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63133990A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599700A (en) * | 1991-10-18 | 1997-02-04 | Firmenich Sa | Process for the production of carboxylic acids from alcohols using saccharomyces |
CN104096851A (en) * | 2014-08-14 | 2014-10-15 | 天津市职业大学 | Superfine silver powder and calcium pyruvate joint production method |
JP2015186450A (en) * | 2014-03-26 | 2015-10-29 | 三菱化学株式会社 | Method for producing organic compound using microorganisms |
-
1986
- 1986-11-21 JP JP27942686A patent/JPS63133990A/en active Pending
Non-Patent Citations (1)
Title |
---|
THE JOURNAL OF BIOLOGICAL CHEMISTRY=1982 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599700A (en) * | 1991-10-18 | 1997-02-04 | Firmenich Sa | Process for the production of carboxylic acids from alcohols using saccharomyces |
JP2015186450A (en) * | 2014-03-26 | 2015-10-29 | 三菱化学株式会社 | Method for producing organic compound using microorganisms |
CN104096851A (en) * | 2014-08-14 | 2014-10-15 | 天津市职业大学 | Superfine silver powder and calcium pyruvate joint production method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63133990A (en) | Production of pyruvic acid | |
JP3630344B2 (en) | Process for producing inositol stereoisomers | |
CN114394892B (en) | Preparation method of (R) -3-hydroxybutyrate | |
CN114436807B (en) | Preparation method of (R) -3-hydroxybutyrate | |
JPH11243983A (en) | Production of (s)-cyanohydrin with enzyme | |
JP3482239B2 (en) | Enzymatic production of aliphatic S-cyanohydrin | |
JPH06256278A (en) | Optically active alpha-carbamoylalkanoic acid derivative and its production | |
JP3194160B2 (en) | Method for producing L-tagatose | |
JP3006615B2 (en) | Method for producing D-β-hydroxy amino acid | |
CN106119307B (en) | Preparation method of alpha-ketoglutaric acid | |
JPH01168292A (en) | Production of d-glyceric acid | |
JP2006314223A (en) | Method for producing glucuronic acid and/or glucuronolactone | |
CN114164238B (en) | Enzymatic synthesis method of L-tyrosine | |
JPS60145095A (en) | Preparation of xylitol by immobilized microorganism | |
JP2009215231A (en) | Method of preparing crystalline 1,5-d-anhydroglucitol | |
CN116515913A (en) | Low-cost bio-based glycolic acid fermentation and separation and purification technology thereof | |
JP4480100B2 (en) | Method for producing L-ascorbic acid-2-phosphate | |
JP2981250B2 (en) | Method for producing D-pantothenonitrile | |
JP2502990B2 (en) | <1> -Process for producing malic acid | |
JP3016647B2 (en) | Preparation of L-serine solution | |
JP3012990B2 (en) | Method for producing D-aspartic acid | |
JPS6225353B2 (en) | ||
JPH09140391A (en) | Production of amino acid by bacterium | |
JPS6191154A (en) | Production of d-lactic acid | |
JP2670130B2 (en) | Method for culturing Rhodococcus bacteria and method for producing 2-ketobutyric acid using the microorganism |